Author Topic: Pregabalin (Lyrica) for alcohol dependence: a critical review of the literature  (Read 87 times)

Offline Chip (OP)

  • Server Admin
  • Hero Member
  • *****
  • Administrator
  • *****
  • Join Date: Dec 2014
  • Location: Australia
  • Posts: 6070
  • Reputation Power: 0
  • Chip has hidden their reputation power
  • Gender: Male
  • Last Login:September 15, 2019, 02:35:08 PM
  • Deeply Confused Learner
source: https://www.ncbi.nlm.nih.gov/pubmed/23132700

Pregabalin for alcohol dependence: a critical review of the literature

November 2012

Abstract

INTRODUCTION:

Alcohol dependence represents a severe pathological disorder associated with a significant rate of morbidity and mortality. To date, limited pharmacological agents exist to treat this disorder, and there is a growing interest for new therapies.

In this context, pregabalin represents a promising strategy. Pregabalin, like gabapentin, selectively binds to the α(2)δsubunit of voltage-gated calcium channels, inhibiting release of excessive levels of excitatory neurotransmitters.

The main focus of this review is the clinical use of pregabalin in alcoholic patients, but the authors also reported some data about chemistry, pharmacology, and pharmacokinetics of this drug.

METHODS:

The authors conducted a PubMed search of clinical human studies published in English from January 2000 to August 2012 using the following search terms: pregabalin alcohol dependence, pregabalin alcohol withdrawal, pregabalin alcoholism.

RESULTS:

The search revealed a total of five studies: two trials for the treatment of alcohol relapse and three articles for the management of alcohol withdrawal syndrome with pregabalin.

The critical review of the literature suggests that pregabalin could be a novel and effective treatment option for the management of alcohol relapse in detoxified patients, whereas until now there have been mixed results for the treatment of alcohol withdrawal syndrome. In particular, pregabalin showed a greater beneficial effect on patients with comorbid conditions such as alcoholism and generalized anxiety disorders. The exact mechanism of action of pregabalin in the management of alcoholism is not well understood but it is thought to be due mainly to the modulation of neurotransmitters such as glutamate and norepinephrine by inhibiting activity-dependent calcium influx in nerve terminals.

CONCLUSION:

Pregabalin, within a dosage of 150-450 mg/day, showed beneficial effects for alcohol relapse prevention and contrasting results for the treatment of the withdrawal syndrome. Its use appears to be safe and well tolerated.
« Last Edit: August 27, 2019, 09:29:29 PM by Chip »
Over 90% of all computer problems can be traced back to the interface between the keyboard and the chair !

Tags:
 

Related Topics

  Subject / Started by Replies Last post
2 Replies
1953 Views
Last post February 11, 2015, 01:08:02 PM
by andrew
17 Replies
6185 Views
Last post April 15, 2016, 01:01:27 PM
by Taytoechip
8 Replies
3125 Views
Last post April 18, 2016, 09:26:54 PM
by DreamerOnTheRun
2 Replies
1964 Views
Last post September 24, 2017, 08:41:23 AM
by Chip
3 Replies
2210 Views
Last post August 28, 2019, 10:11:38 AM
by Chip
4 Replies
2426 Views
Last post February 24, 2017, 10:24:37 PM
by hanna
2 Replies
1644 Views
Last post February 23, 2017, 05:39:39 AM
by Chip
0 Replies
461 Views
Last post May 02, 2018, 01:33:09 PM
by smfadmin
0 Replies
100 Views
Last post June 01, 2019, 06:29:15 AM
by Chip
0 Replies
88 Views
Last post July 05, 2019, 09:01:12 AM
by Chip




TERMS AND CONDITIONS

In no event will d&u or any person involved in creating, producing, or distributing site information be liable for any direct, indirect, incidental, punitive, special or consequential damages arising out of the use of or inability to use d&u. You agree to indemnify and hold harmless d&u, its domain founders, sponsors, maintainers, server administrators, volunteers and contributors from and against all liability, claims, damages, costs and expenses, including legal fees, that arise directly or indirectly from the use of any part of the d&u site.


TO USE THIS WEBSITE YOU MUST AGREE TO THE TERMS AND CONDITIONS ABOVE



Founded December 2014